Literature DB >> 10970872

Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

H M Zhou1, A Nichols, P Meda, J D Vassalli.   

Abstract

Urokinase-type plasminogen activator (uPA) is a potent catalyst of extracellular proteolysis, which also binds to a high-affinity plasma membrane receptor (uPAR). Binding of uPA may influence pericellular proteolysis and/or activate intracellular signal transduction. Transgenic mice overexpressing either uPA or uPAR in basal epidermis and hair follicles had no detectable cutaneous alterations. In contrast, bi-transgenic mice overexpressing both uPA and uPAR, obtained by crossing the two transgenic lines, developed extensive alopecia induced by involution of hair follicles, epidermal thickening and sub-epidermal blisters. The phenotype was due to uPA catalytic activity since combined overexpression of uPAR and uPAR-binding but catalytically inactive uPA in the same tissue was not detrimental in another bi-transgenic line. It was accompanied by increased plasmin-generating capacity, up-regulation and activation of matrix metalloproteinases type-2 and -9, and cleavage of uPAR. Thus, combined overexpression of uPA and uPAR acts in synergy to promote pathogenic extracellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970872      PMCID: PMC302082          DOI: 10.1093/emboj/19.17.4817

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

1.  Plasminogen activator in cultured human epidermal cells.

Authors:  K Hashimoto; K H Singer; W B Lide; K Shafran; P Webber; S Morioka; G S Lazarus
Journal:  J Invest Dermatol       Date:  1983-11       Impact factor: 8.551

Review 2.  Natural inhibitors of fibrinolysis.

Authors:  D Collen
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 3.  Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.

Authors:  M J Duffy; T M Maguire; E W McDermott; N O'Higgins
Journal:  J Surg Oncol       Date:  1999-06       Impact factor: 3.454

4.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.

Authors:  E Appella; E A Robinson; S J Ullrich; M P Stoppelli; A Corti; G Cassani; F Blasi
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

5.  Glycogen metabolism in psoriatic epidermis and in regenerating epidermis.

Authors:  C S Harmon; P J Phizackerley
Journal:  Clin Sci (Lond)       Date:  1984-09       Impact factor: 6.124

6.  Plasminogen is present in the basal layer of the epidermis.

Authors:  R R Isseroff; D B Rifkin
Journal:  J Invest Dermatol       Date:  1983-04       Impact factor: 8.551

7.  Migrating keratinocytes express urokinase-type plasminogen activator.

Authors:  S Morioka; G S Lazarus; J L Baird; P J Jensen
Journal:  J Invest Dermatol       Date:  1987-04       Impact factor: 8.551

8.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.

Authors:  E F Plow; D E Freaney; J Plescia; L A Miles
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

9.  Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.

Authors:  J A Aguirre Ghiso; K Kovalski; L Ossowski
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

10.  Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

Authors:  J D Vassalli; J M Dayer; A Wohlwend; D Belin
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  19 in total

1.  Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

Authors:  Kasper Almholt; Ole Didrik Lærum; Boye Schnack Nielsen; Ida Katrine Lund; Leif Røge Lund; John Rømer; Annika Jögi
Journal:  Clin Exp Metastasis       Date:  2015-06-04       Impact factor: 5.150

Review 2.  Proteolytic networks in cancer.

Authors:  Steven D Mason; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2011-01-12       Impact factor: 20.808

3.  Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Authors:  Paola Llinas; Marie Hélène Le Du; Henrik Gårdsvoll; Keld Danø; Michael Ploug; Bernard Gilquin; Enrico A Stura; André Ménez
Journal:  EMBO J       Date:  2005-04-07       Impact factor: 11.598

4.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

Authors:  M Resnati; I Pallavicini; J M Wang; J Oppenheim; C N Serhan; M Romano; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation.

Authors:  Brian M Connolly; Eun Young Choi; Henrik Gårdsvoll; Alexandra L Bey; Brooke M Currie; Triantafyllos Chavakis; Shihui Liu; Alfredo Molinolo; Michael Ploug; Stephen H Leppla; Thomas H Bugge
Journal:  Blood       Date:  2010-05-13       Impact factor: 22.113

6.  Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.

Authors:  Baogang J Xu; Wenwei Yan; Bojana Jovanovic; Angel Q An; Nikki Cheng; Mary E Aakre; Yajun Yi; Jimmy Eng; Andrew J Link; Harold L Moses
Journal:  Proteomics       Date:  2010-07       Impact factor: 3.984

7.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

8.  The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.

Authors:  Niels Behrendt; Karin List; Peter A Andreasen; Keld Danø
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

Review 9.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

10.  Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer.

Authors:  A F Lomholt; G Høyer-Hansen; H J Nielsen; I J Christensen
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.